Presence of an Artificial Intelligence–powered Predictive Biomarker Is Associated with a Poor Response to Intravesical Bacillus Calmette-Guerin but Not to Intravesical Sequential Gemcitabine/Docetaxel in Patients with High-grade Non–muscle-invasive Bladder CancerVignesh T. Packiam, Patrick J. Hensley, Anand Rajan et al.|European Urology Oncology|2025Cited by 6
ONCOLOGIC OUTCOMES OF BLADDER-SPARING MANAGEMENT FOR HIGH-GRADE NON-INVASIVE UROTHELIAL CARCINOMA OF THE PROSTATIC URETHRAAlexander C. Martin, Vignesh T. Packiam, Ian M. McElree et al.|Urologic Oncology Seminars and Original Investigations|2024Cited by 2
PD14-05 LONG-TERM FOLLOW-UP OF INTRAVESICAL GEMCITABINE AND DOCETAXEL AS RESCUE THERAPY FOR NON-MUSCLE INVASIVE BLADDER CANCERPhani T. Chevuru, Vignesh T. Packiam, Ian M. McElree et al.|The Journal of Urology|2022Cited by 0
Recurrent heterotopic ossification following open radical nephrectomyJordan R. Richards, Vignesh T. Packiam, Ian M. McElree et al.|Urology Case Reports|2023Cited by 0